You have 9 free searches left this month | for more free features.

mk-3475

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Cancer Trial in Japan (drug, procedure, radiation)

Not yet recruiting
  • Bladder Cancer
  • MK-3475
  • +3 more
  • Kobe, Hyogo, Japan
  • +3 more
May 26, 2023

Colorectal Cancer Trial in Baltimore (Oral CC-486, Romidepsin, MK-3475)

Completed
  • Colorectal Cancer
  • Oral CC-486
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 21, 2022

Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

Not yet recruiting
  • Untreated Advanced or Recurrent Thymic Carcinomas
  • MK-3475
  • +3 more
  • Chuo, Tokyo, Japan
    National Cancer Center Hospital
Apr 16, 2023

NSCLC Trial in Portland (MK-3475, Gemcitabine)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Portland, Oregon
  • +1 more
Jan 31, 2022

Melanoma, Lung Cancer Trial in New Haven (MK-3475, Stereotactic Body Radiation Therapy (SBRT))

Suspended
  • Melanoma
  • Lung Cancer
  • MK-3475
  • Stereotactic Body Radiation Therapy (SBRT)
  • New Haven, Connecticut
    Yale Cancer Center
Oct 5, 2021

Brain Cancer Trial in United States (MK-3475)

Completed
  • Brain Cancer
  • MK-3475
  • Los Angeles, California
  • +6 more
Jun 6, 2022

Melanoma Trial in Pittsburgh (MK-3475, Peginterferon alfa-2b)

Completed
  • Melanoma
  • MK-3475
  • Peginterferon alfa-2b
  • Pittsburgh, Pennsylvania
    Hillman Cancer Center
May 3, 2021

Melanoma, NSCLC, Brain Metastases Trial in New Haven (MK-3475)

Completed
  • Melanoma
  • +2 more
  • MK-3475
  • New Haven, Connecticut
    Smilow Cancer Center at Yale New Haven Hospital
Mar 22, 2021

NSCLC Trial in United States (MK-3475, Carboplatin, Paclitaxel)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • MK-3475
  • +3 more
  • La Jolla, California
  • +14 more
Oct 1, 2021

NSCLC Trial in Mexico city (MK-3475, Docetaxel)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Mexico city, Distrito Federal, Mexico
    National Cancer Institute of Mexico
Dec 14, 2020

Recurrent Head Neck Cancer, Carcinoma, Squamous Cell of Head and Neck Trial in Baltimore, Philadelphia, Pittsburgh

Recruiting
  • Recurrent Head and Neck Cancer
  • Carcinoma, Squamous Cell of Head and Neck
  • Reirradiation
  • MK-3475
  • Baltimore, Maryland
  • +3 more
Mar 25, 2022

Endometrial Cancer, Endometrial Carcinoma, Tumors, Endometrial Trial in Saint Louis (drug, procedure, radiation)

Completed
  • Endometrial Cancer
  • +2 more
  • MK-3475
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 6, 2020

NSCLC Trial in United States (Imprime PGG, MK-3475)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Imprime PGG
  • MK-3475
  • Chicago, Illinois
  • +4 more
Oct 6, 2022

Clear Cell Renal Carcinoma Trial in United States (MK-3475, Bevacizumab)

Completed
  • Clear Cell Renal Carcinoma
  • Chicago, Illinois
  • +8 more
Jul 8, 2020

Carcinoma, Renal Cell Trial in United Kingdom, United States (Pazopanib, MK-3475)

Completed
  • Carcinoma, Renal Cell
  • Boston, Massachusetts
  • +5 more
Feb 28, 2020

Multiple Myeloma Trial in Baltimore (MK-3475, Pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • MK-3475
  • +2 more
  • Baltimore, Maryland
    Greenebaum Cancer Center at University of Maryland Medical Cente
Nov 1, 2019

Advanced GI Cancer Trial in Salt Lake City (MK-3475)

Terminated
  • Advanced GI Cancer
  • MK-3475
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Nov 8, 2018

Multiple Myeloma Trial in Ann Arbor, Milwaukee (Autologous Stem Cell Transplant, Melphalan, Lenalidomide)

Completed
  • Multiple Myeloma
  • Autologous Stem Cell Transplant
  • +3 more
  • Ann Arbor, Michigan
  • +1 more
Jul 2, 2018

Breast Tumors, Bone Tumors Trial in Melbourne (Stereotactic Ablative Body Radiosurgery (SABR), MK-3475)

Completed
  • Breast Neoplasms
  • Bone Neoplasms
  • Stereotactic Ablative Body Radiosurgery (SABR)
  • MK-3475
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Oct 17, 2017